Study identifier:NIS-OAT-ARI-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Breast cancer Tumor care patient observation programme
Post menopausal
N/A
No
anastrozole
Female
200
Observational
18 Years - 100 Years
Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
1 | Drug: anastrozole Oral Other Name: Arimidex |